Long-term survival in patients with advanced melanoma, renal cell carcinoma, or non-small cell lung cancer treated with nivolumab

被引：0
|
作者：
Topalian, Suzanne L. [1 ]
Hodi, F. Stephen [2 ]
Brahmer, Julie R. [3 ]
Gettinger, Scott N. [4 ]
Smith, David C. [5 ]
McDermott, David F. [6 ]
Powderly, John D. [7 ]
Sosman, Jeffrey A. [8 ]
Atkins, Michael B. [9 ]
Spigel, David R. [10 ]
Antonia, Scott J. [11 ]
Drilon, Alexander [12 ]
Bhore, Rafia [13 ]
Hosein, Fareeda [13 ]
Sznol, Mario [4 ]
机构：
[1] Johns Hopkins Bloomberg Kimmel Inst Canc Immunoth, Baltimore, MD USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
[4] Yale Canc Ctr, New Haven, CT USA
[5] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
[6] Dana Farber Harvard Canc Ctr, Beth Israel Deaconess Med Ctr, Boston, MA USA
[7] Carolina Biooncol Inst, Huntersville, NC USA
[8] Northwestern Univ, Med Ctr, Chicago, IL 60611 USA
[9] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
[10] Sarah Cannon Res Inst, Lung Canc Res Program, Nashville, TN USA
[11] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[12] Mem Sloan Kettering Canc Hosp, New York, NY USA
[13] Bristol Myers Squibb, Princeton, NJ USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P216
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Survival, Durable Response, and Long-Term Safety in Patients With Previously Treated Advanced Renal Cell Carcinoma Receiving Nivolumab
    McDermott, David F.
    Drake, Charles G.
    Sznol, Mario
    Choueiri, Toni K.
    Powderly, John D.
    Smith, David C.
    Brahmer, Julie R.
    Carvajal, Richard D.
    Hammers, Hans J.
    Puzanov, Igor
    Hodi, F. Stephen
    Kluger, Harriet M.
    Topalian, Suzanne L.
    Pardoll, Drew M.
    Wigginton, Jon M.
    Kollia, Georgia D.
    Gupta, Ashok
    McDonald, Dan
    Sankar, Vindira
    Sosman, Jeffrey A.
    Atkins, Michael B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (18) : 2013 - U42
  • [22] Statins improve survival in patients previously treated with nivolumab for advanced non-small cell lung cancer: An observational study
    Omori, Miwako
    Okuma, Yusuke
    Hakozaki, Taiki
    Hosomi, Yukio
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2019, 10 (01) : 137 - 143
  • [23] Clinical features of patients with advanced non-squamous non-small cell lung cancer treated with long-term pemetrexed
    Hirai, Kenichiro
    Yokouchi, Hiroshi
    Azuma, Keisuke
    Minemura, Hiroyuki
    Sekine, Satoko
    Kanazawa, Kenya
    Tanino, Yoshinori
    Munakata, Mitsuru
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 123 - 123
  • [24] Preoperative renal dysfunction and long-term survival after surgery for non-small cell lung cancer
    Saito, Tomohito
    Murakawa, Tomohiro
    Shintani, Yasushi
    Okami, Jiro
    Miyaoka, Etsuo
    Yoshino, Ichiro
    Date, Hiroshi
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (01): : 227 - +
  • [25] Obesity is associated with long-term improved survival in definitively treated locally advanced non-small cell lung cancer (NSCLC)
    Lam, Vincent K.
    Bentzen, Soren M.
    Mohindra, Pranshu
    Nichols, Elizabeth M.
    Bhooshan, Neha
    Vyfhuis, Melissa
    Scilla, Katherine A.
    Feigenberg, Steven J.
    Edelman, Martin J.
    Feliciano, Josephine L.
    [J]. LUNG CANCER, 2017, 104 : 52 - 57
  • [26] Long-term survival of locally advanced stage III non-small cell lung cancer patients treated with chemoradiotherapy and perspectives for the treatment with immunotherapy
    Vrankar, Martina
    Stanic, Karmen
    [J]. RADIOLOGY AND ONCOLOGY, 2018, 52 (03) : 281 - 288
  • [27] A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
    Hurkmans, Daan P.
    Basak, Edwin A.
    van Dijk, Tanja
    Mercieca, Darlene
    Schreurs, Marco W. J.
    Wijkhuijs, Annemarie J. M.
    Bins, Sander
    Oomen-de Hoop, Esther
    Debets, Reno
    Joerger, Markus
    Odink, Arlette
    van der Veldt, Astrid A. M.
    van der Leest, Cor H.
    Aerts, Joachim G. J., V
    Mathijssen, Ron H. J.
    Koolen, Stijn L. W.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [28] A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
    Hurkmans, D. P.
    Basak, E. A.
    van Dijk, T.
    Mercieca, D.
    Schreurs, M. W. J.
    Wijkhuijs, A. J. M.
    Bins, S.
    Oomen-de Hoop, E.
    Debets, R.
    Joerger, M.
    Odink, A.
    Van der Veldt, A. A. M.
    Van der Leest, C. H.
    Aerts, J. G.
    Mathijssen, R. H. J.
    Koolen, S. L.
    [J]. ANNALS OF ONCOLOGY, 2019, 30
  • [29] A retrospective analysis of non-small cell lung cancer patients treated with nivolumab
    Akagi, Kazumasa
    Honda, Noritaka
    Umeyama, Yasuhiro
    Ogawara, Daiki
    Ikeda, Takaya
    Yamaguchi, Hiroyuki
    Kitazaki, Takeshi
    Nakatomi, Katsumi
    Fukuda, Minoru
    Mukae, Hiroshi
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [30] Conditional Survival in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab
    Shao, Ning
    Wan, Fangning
    Zhu, Yao
    Ye, Dingwei
    [J]. MEDICAL SCIENCE MONITOR, 2019, 25 : 6518 - 6522
12345